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KESAN PENURUNAN PARAS GLUKOSA-DARAH OLEH  EKSTRAK  BIJI  
SWIETENIA  MACROPHYLLA  DALAM TIKUS NORMAL DAN TIKUS  
DIABETIK TERARUH -STREPTOZOTOCIN 
ABSTRAK 
Biji S.macrophylla telah digunapakai oleh orang yang terdahulu untuk merawat 
pelbagai jenis penyakit termasuk diabetes. Matlamat kajian  ini adalah untuk menyiasat 
aktiviti antidiabetik ekstrak tumbuhan ini dan menentukan sebatian aktif yang mungkin 
menyumbang kepada aktiviti tersebut.  Biji S.macrophylla yang telah hancur dan kering, 
diekstrak secara bersiri dengan  Petroleum-eter, kloroform, metanol dan juga air melalui 
dua kaedah berbeza; pengekstrakan Soxhlet dan juga kaedah  maserasi. Ekstrak-ekstrak 
yang diperolehi , diuji bagi aktiviti hipoglisemik ke atas tikus normal, perencatan 
kenaikan paras glukosa darah dalam ujian toleransi glukosa secara intraperitoneal 
(IPGTT) dan juga aktiviti antihiperglisemia  ke atas tikus diabetik teraruh- 
streptozotocin. 
Semua ekstrak daripada  kaedah  pengekstrakan Soxhlet didapati tidak 
mempunyai aktiviti antidiabetik. Manakala bagi ekstrak yang diperolehi melalui kaedah 
maserasi, didapati bahawa tiada ekstrak yang dapat menurunkan paras glukosa darah 
dalam ujian hipoglisemik ke atas tikus normal. Walaubagaimanapun, ekstrak petroleum-
eter dan juga air yang diperolehi melalui kaedah maserasi, merencat dengan signifikan 
kenaikan paras glukosa darah dalam ujian IPGTT. Bagi tikus diabetik teraruh- 
streptozotocin, hanya ekstrak air berupaya menurunkan paras glukosa darah selepas 3, 5 
dan 7 jam pemberian. Pemberian ekstrak petroleum-eter dan juga air secara oral 
sebanyak dua kali sehari, ke atas tikus diabetik menunjukkan hanya ekstrak air 
(1000mg/kg/sehari) dengan signifikan  menurunkan paras glukosa darah puasa selepas 
xx 
 
empat belas hari rawatan. Ekstrak air biji S.macrophylla kemudiannya difraksikan 
dengan kloroform, etil-asetat dan juga n-butanol. 
Ujian selanjutnya menunjukkan bahawa fraksi  n-butanol  adalah  yang paling 
poten dalam  menurunkan  paras glukosa darah puasa tikus diabetik teraruh- 
streptozotocin. Fraksi n-butanol didapati meningkatkan dengan signifikan penggunaan 
glukosa oleh sediaan  otot abdomen terasing  dan juga merencat penyerapan glukosa 
oleh kantung usus terbalik terasing. Ini  mencadangkan  bahawa kesan penurunan  paras 
glukosa darah oleh fraksi n-butanol, setidak-tidaknya adalah melalui  perencatan  
penyerapan glukosa pada saluran gastrousus dan juga meningkatkan  penggunaan 
glukosa oleh  otot. Analisa ekstrak petroleum-eter dengan  menggunakan spektrometer 
jirim-kromatografi gas (GCMS) menunjukkan kehadiran fukosterol, β-sitosterol, asid 
linoleik dan juga γ-tokoferol yang mungkin bertanggungjawab ke atas aktiviti anti-
hiperglisemik. Analisa ke atas fraksi  n-butanol dengan  menggunakan  ujian saringan 
fitokimia dan  juga spektrometer  jirim-kromatografi cecair (LCMS) masing-masing 
telah menunjukkan  fraksi tersebut mengandungi flavonoid, alkaloid dan juga saponin, 
dan flavonoid yang telah dikenalpasti adalah rutin dan isoquercitrin.   
Kesimpulannya, kesan  penurunan glukosa mungkin disumbangkan oleh sebatian 
tak berkutub yang merencat kenaikan paras glukosa darah ke atas tikus yang diberikan 
glukosa dan juga sebatian berkutub yang menurunkan paras glukosa darah ke atas tikus 
diabetik teraruh-streptozotocin. Penemuan-penemuan ini menyokong penggunaan 
tradisional Swietenia macrophylla  untuk merawat diabetes 
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BLOOD-GLUCOSE  LOWERING  EFFECT OF  SWIETENIA MACROPHYLLA  
SEED  EXTRACTS IN NORMAL AND STREPTOZOTOCIN-INDUCED 
DIABETIC RATS 
 
ABSTRACT 
 Swietenia macrophylla  (meliaceae) seeds have been used in folklore for treating 
various  diseases  including diabetes. The aim  of  the present work was to investigate 
the antidiabetic activity of the plant extracts and determine the active compound(s) that 
might  contribute to the activity. Pulverized, dried powder of  S. macrophylla  seeds was 
extracted serially with petroleum ether, chloroform, methanol and  water  by two 
different methods; Soxhlet extraction and maceration methods. The extracts obtained 
were examined for hypoglycaemic activity in normal rats, inhibition of the rise of blood 
glucose level in intraperitoneal glucose tolerance test (IPGTT) and antihyperglycaemic 
activity in streptozotocin-induced diabetic rats. 
 It was found that  all the extracts obtained from Soxhlet method did not possess 
antidiabetic activity. As for the extracts obtained from the maceration method, none of 
the extracts lowered the blood glucose levels in hypoglycaemic test in normal rats. 
However, petroleum-ether and aqueous extracts  obtained by maceration method 
significantly inhibited the rise of blood glucose levels in IPGTT. In streptozotocin-
induced diabetic rats, only aqueous extract at 3,5 and 7 hours after administration 
reduced the blood glucose level. Twice daily oral administration of aqueous and 
petroleum-ether extracts  to diabetic rats showed that only aqueous extract 
(1000mg/kg/daily) significantly decreased the fasting blood glucose levels after 14 days 
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treatment. The  aqueous extract of  S. macrophylla seeds was then fractionated with 
chloroform, ethyl-acetate and n-butanol. 
 Further test showed  that n-butanol fraction was the most potent in lowering the 
fasting blood glucose levels in streptozotocin-induced diabetic rats. The n-butanol 
fraction  significantly increase  the utilization of glucose by isolated abdominal muscles 
preparation and inhibited glucose absorption  by isolated everted intestine. It may 
suggests that the blood glucose lowering effect of n-butanol fraction  is by inhibition of 
glucose absorption in gastrointestinal tract and increasing utilization of glucose by 
muscles. Analysis of  petroleum-ether extract by Gas-chromatography-mass 
spectrometer (GC-MS) showed the presence of fucosterol, β-sitosterol, linoleic acid and 
γ-tocopherol that might be responsible for the antihyperglycaemic activity. Analysis of 
n-butanol fraction, using phytochemical screening and LC-MS respectively indicated 
that the fraction contained flavonoids, alkaloids and saponins and the flavonoids that 
have been identified were rutin and isoquercitrin. 
 In conclusion, the glucose lowering effect might be contributed by the 
non polar compound(s) which inhibit the rise in blood glucose level in glucose loaded 
rats and  polar compound(s) which reduced  the blood glucose level in streptozotocin-
induced diabetic rats. These findings support the traditional use of  Swietenia 
macrophylla for treatment of diabetes. 
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CHAPTER  1 
 
INTRODUCTION 
 
1.0 Pharmacognosy 
 
Pharmacognosy is the study of drugs of natural origin. It is one of the five 
major divisions of the pharmaceutical curriculum. In other words, pharmacognosy also 
means a knowledge of drugs or pharmaceuticals, that has been a part of healing arts and 
sciences, since mankind first began to treat illnesses (Varro et al., 1988). The ancient 
people, gathered herbs, animals, plants, and minerals and concocted them into plenty of 
ill-flavoured pungent mixtures, in order to treat diseases. The way of creating 
medication have progressed from an era of empiricism to the present age of specific 
therapeutic agent. 
 
Recently, as a result of the intense concern with all aspects of ecology, there has 
been a renewed interest in so-called  “natural” foods and drugs. The availability of an 
extremely wide variety of these products, ranging from the mint tea to ginseng chewing 
gum, has stimulated the scientific community to learn more about them. Nowadays, 
some natural compounds of drugs constituents have been partially replaced in commerce 
by synthetic compounds of  identical chemical structure and therapeutic properties. For  
instance, natural camphor  is obtained from  the camphor  tree by steam distillation, but 
in contrast, synthetic camphor  was manufactured by either of  two methods: by total 
synthesis from vinyl chloride  and cyclopentadiene (a complete synthetic process) or 
semi  synthesis from pine stumps (involve chemical modification of a natural product) 
illnesses ( Varro et al., 1988). 
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In future, the achievements of science and technology will be so great that, when 
 
brought to bear upon the  mysteries of nature that have long puzzled us, those mysteries 
 
will yield their secrets amazingly. The plant and animal kingdoms will continue to serve 
 
mankind  in the 21st century just as they have done since the dawn of  history. 
Significant new drugs of natural origin and new methods of producing them will  
continue to be important parts for sustainability of human kinds.  
 
 
1.1  Herbs as an alternative medicine  
 
In recent years, medicinal herbs and their preparations have been increasingly 
considered in the treatment of illness, and at the  the same time, Malaysia is a country 
that treasures  its natural forests. These forests are the largest source of natural products 
which can be used for medicinal purpose. Since the early years, the Malays have been 
using plant products such as the leaves, seeds, roots, stems, flowers and fruit as 
ingredients  in the preparation of  traditional medicine. In the old days, plants were used 
primarily for treatment rather than  cure, due to the tendency of practitioners of 
traditional medicine diagnosed diseases in a holistic manner. However, traditional 
medicine remains a popular method of treatment since it has been used in immemorial 
time until today.  
Malaysia is a country with plenty of  natural resources, rich with medicinal values. 
There are over 6000 species of tropical plants all over the country. Only in Peninsular 
Malaysia , there are 550 genera containing 1,300 species and most of these are medicinal 
plants good for the human body (Muhammad & Mustafa.,1994). Most drugs currently 
used as medicine today, are products of synthetic chemicals derived from  natural 
chemicals. There are many types of traditional medicines that are widely used in 
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Malaysia for treating diabetes.  It is a mixture of various plant parts. Some of the plants 
commonly used in Malaysia for treating diabetes are listed in Table 1. The composition 
of the herbs mixture varies in different places.  
 
 
Local name 
 
Scientific name 
 
Family 
 
Part Used 
 
Mengkudu 
 
Morinda citrifolia L 
 
Rubiaceae 
 
Leaves 
 
Lidah buaya 
 
Aloe vera L. 
 
Liliaceae 
 
Leaves  
 
Kunyit 
 
Curcuma Domestica 
Val. 
 
Zingiberceae 
 
Rhizome 
 
Kacang soya 
 
Glycine max [L.] 
Merr. 
 
Papilionaceae 
(Leguminoceae). 
 
Seeds 
 
Jambu batu 
 
Psidium guava L 
 
Myrtaceae 
 
Fruit 
 
Bawang merah 
 
Allium cepa L. 
 
Liliaceae 
 
The entire parts 
 
Table 1.1 : Some of  the herbs commonly used in Malaysia for treating diabetes. 
Sources : (http://jamu-herbal.com, accessed on 2 July 2009) 
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1.2 Compounds  from herbs with antidiabetic activity 
Anti-diabetic secondary metabolites 
Diabetes mellitus is a debilitating and often life-threatening disorder with 
increasing incidence throughout the world (WHO, 1985). Literature surveys show that 
more than 400 plant species were reported to have  anti-diabetic  activity, and most of 
the anti-diabetic natural products were, so far, isolated from plants (Mukherjee, 1981; 
Rai, 1995).  
 
SECONDARY METABOLITES 
 
 
Description 
 
 
 
Flavonoids 
 
Originate from a large group of polyphenolic 
compounds, commonly in plants.There are 
the pigments responsible for the shades of 
yellow, orange and red in flowering plants. 
Many are endowed with biological activities, 
such as anti-diabetic, anti-
inflammatory,antiallergic, antischemic, 
antiplatelet  and  anti-tumoral activities. 
(Catherine and Lester, 2003) 
 
 
 
Alkaloids 
 
 
 
An organic nitrogenous compounds with a 
limited distribution in nature. May occur in 
various parts of the  plants: in seeds, fruits,  
leaves, in underground stems,  roots,  
rhizomes and barks. The pharmacologic 
actions varies widely : from anti-diabetic to 
analgesics and narcotics whereas others are 
central stimulants.  (Varro et al.,1988). 
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Diterpenes 
 
Naturally occurring organic compounds that 
comprise two monoterpene molecules; found 
in some essential oils; reported to  have 
antibacterial, anti-diabetic, antiviral, 
antifungal, anti-inflammatory and 
expectorant properties  ( Jonas., 2005) 
 
 
 
Triterpenoids 
 
 
 
Terpenoid derivatives of  triterpene 
molecules. They may have useful activities 
including immunostimulation, anti-tumour-
promoting activity, antiinflammatory and  
anti-cancer  properties . ( Joseph et al., 2002) 
  
 
 
 
Sesquiterpene lactones 
 
 
It is another member of the terpene group; 
comprises three units of isoprene. Molecular 
formula is C15H24O6. Reported  to be useful 
as an antiseptic, antibacterial,  or anti-
inflammatory, anti-diabetic  and as a calming 
agent by aromatherapists. 
( Jonas., 2005). 
 
 
 
 
Saponins 
 
 
A group of glycosides that is widely 
distributed in the higher plants. It form 
colloidal solutions in water  that foam  upon 
shaking. They have a bitter and acrid taste .  
Saponins  have been  reported  to beneficial 
to control  blood cholesterol levels, bone 
health, cancer, diabetic and  building up of 
the  immune system.  (Varro et al., 1988). 
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Anthocyanins 
 
 
Water-soluble, terrestrial plant pigments that 
can be classified chemically as both 
flavonoid and  phenolic. Act as a colouring 
agents for fruit juices  and  wine. These 
pigments are linked to an amazingly broad  
range of health benefits such as treating 
diabetes, hypertension, vision disorders, 
microbial infections and also diarrhea.           
( Jonas., 2005) 
 
 
 
 
Lignans 
 
A type of  polyphenolic compound that 
occurs naturally in some plants. Sources that 
are particularly rich in lignin, in order of 
highest to lowest concentration are, flax, 
sesame, sunflower, and pumpkin seeds. This 
substance has an excellent anti-oxidant 
properties and  belief  to help in preventing 
the development of  diabetes  and 
arteriosclerosis.  (Iqbal ahmad  et al.,  2006)                                
 
 
 
 
Tannins 
 
 
A  naturally occurring  polyphenolic 
compound  with  antioxidant and 
anticarcinogenic effects. In vitro/animal 
studies indicate it may have health benefits 
in treating diabetes   (Liu X et al., 2005) 
 
 
Table 1.2 : Some of the secondary metabolites that have been  reported  to have   
anti-diabetic properties.                                                        
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1.3 Approaches to anti-diabetic screening of  S. macrophylla  seeds extract. 
 
1.3.1 Extraction of   S. macrophylla  seeds. 
 
  
Extraction is a process of  transfering a solute from one phase to another. In other 
words, this is the separation of a substance from a mixture by  dissolving that substance 
in a suitable solvent. Extraction is one of the important parts in bioactivity guided 
isolation study. Figure 1.1 shows the flow chart for the study of  plants used in 
traditional medicine (Luc Pieters & Arnold., 2005). 
A successful extraction, should begin with careful selection of solvents and 
preparation of the plant samples. The extraction  method chosen should try to minimize 
interference from compounds that  may  be  co-extracted  with the target compounds, 
and contamination of the extract obtained. The extraction method used if possible can 
prevent decomposition of  important metabolites or avoid artifact formation as a result of 
extraction conditions or solvent impurities. In this  study,’ serial extraction’ has been 
chosen as the method of extraction . Serial extraction refers to the use of  increasing  
polarity of solvents in order to remove different polarity of  secondary metabolites from 
the plants. The solvents  used in this study were petroleum ether, chloroform, methanol 
and water. 
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1.3.2  In-vivo and  in-vitro studies of  S. macrophylla  seeds extracts  
 
1.3.2.1 In-vivo experiment. 
 
 
 In- vivo experiment  defines as experiment conducted  in a living body.  In vivo 
testing  is often employed  over in vitro because it provided overall effects of an 
experiment on a living subject (Wikipedia.org, accessed on 10 Dec. 2010). This is due 
to, some conditions  in the in-vitro are unrealistic or unsimilar to the actual environment 
within the living organism. For instance, if  the active entity of a substance is  its 
metabolite, the substance  might not show any activity if being tested using  in-vitro 
method.  In this study, we have chosen  three different  in-vivo experiments  using the 
actual animal models , which includes both normal and diabetic rats. The experiments 
are hypoglycemic and  intraperitoneal glucose tolerance tests  in normal rats, and  also 
antihyperglycaemic test in  diabetic rats. 
 For the animal models of  diabetes mellitus, the condition can be induced 
through pharmacological, surgical or genetic manipulations in several animal species. 
Most experiments in diabetes are carried out on rodents, although some studies are  
performed in larger animals. The classical model employed by Banting and Best was 
pancreatectomy in dogs (Bliss, 2000). However, majority of studies published in the 
field of ethnopharmacology between 1996 and 2006 employed  models, where  diabetes 
was induced through administration of chemicals such as streptozotocin (STZ, 69%) and 
alloxan (31%). This model has been useful for the study of multiple aspects of the 
disease. Both drugs exert their diabetogenic action when they are administered 
parenterally: intravenously, intraperitoneally or subcutaneously. The dose of these 
agents required for inducing diabetes depends on the animal species, route of 
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administration and nutritional status. According to the administered dose of these agents, 
syndromes similar to either type 1, type 2 diabetes mellitus or glucose intolerance can be 
induced (Lenzen et al., 1996; Mythili et al., 2004). Methods are available, but the pH 
and type of buffer employed as well as the preparation of the solution of either alloxan 
or streptozotocin in the day of the experiments are still arguable (Yu et al., 2000; Lei et 
al., 2005;; Miranda et al., 2006). 
In this study, the diabetic rats are being induced by a single intraperitoneal (i.p) 
injection of  60mg/kg streptozotocin(STZ) dissolved immediately in normal saline (0.9% 
NaCl, pH 4.5) before used, in overnight (16 hours) fasted rats (Dominguez et al,. 2000). 
Hyperglycemia (diabetes) was confirmed by the elevated blood glucose level  
determined at 72 hours after STZ injection and the symptom  of polyurea. The rats found 
with a fasting blood glucose (FBG) level above 15mmol/L were considered to be 
diabetic and used in the experiment. 
 
1.3.2.2  In-vitro experiment 
 
In vitro is the opposite of in vivo, which means a biological  process or  
experiment that is performed not in a living organism but in a controlled environment, 
such as in a test tube or Petri dish (Kail et al., 2006). In-vitro test  involved the use of 
organs, tissues, cells, cellular components, proteins, and/or biomolecules. It is a better 
test for deducing biological mechanisms of action compare to the in-vivo approach. 
However, the controlled conditions present in the in vitro system differ significantly 
from those in vivo, and  may give misleading results due to the fact  that living 
organisms are extremely complex functional systems that are made up of  genes, protein 
molecules, RNA molecules, small organic compounds, inorganic ions and complexes in 
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an environment that is spatially organized by membranes and, in the case of 
multicellular organisms, organ systems  (Alberts and Bruce., 2008). Therefore, in vitro 
studies are usually followed by in vivo studies. In this study, we used the isolated tissue 
preparation in order to determine or elucidate the mechanism of actions of the extract. 
Two different experiments will be carried out to determine whether the 
antihyperglycaemic properties of these extracts act through extrapancreatic mechanism 
of action. The first experiment  involve the study of glucose uptake by muscles using 
isolated abdominal muscle preparation of  Gray and Flatt, (1998) with some 
modification. Another experiment is to study the effect of the extracts on glucose 
absorption  in the gastrointestinal tract by using the modified averted sac technique of 
Wilson and Wiseman, (1954). Increase of glucose uptake by muscles and  inhibition of 
glucose absorption in the gastrointestinal tract are among the extrapancreatic 
mechanisms known to cause the lowering of blood glucose levels.   
1.3.3 Single dose and repeated  doses (14 days) studies 
   Acute studies (single dose)  are short-term studies with exposure periods usually 
less than 24 hours or  maybe last  for  48 to 96 hours.  This study is usually implemented  
for the purpose of screening for  various kinds of  bio-activities in living organism.  
Opposite to the acute study, is the chronic study (repeated doses). In certain 
conditions, a single dose study might not give positive result or exert any potential bio-
activity when being  tested.  However, this does not conclude that the bio-activities are 
not there or  in other words the plant or compound do not possess the bio-activity. 
Chronic study (repeated dose) in animals are usually necessary to evaluate toxic 
characteristics of a chemical arise from repeated  exposure over a  period of time. 
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Repeated  dose  studies, mostly have been carried out after  initial information on 
toxicity has been obtained from acute toxicity test. Duration of exposure normally 
depends on nature of chemical and circumstances.    
In  my study for the fourteen days treatment, the extracts  were administered 
orally,  twice daily  (9.00 a.m and 9.00 p.m) for fourteen days . The animals were 
observed  individually after dosing, daily  for fourteen days. Each animal was observed 
for toxic sign and recorded. Body weight and fasting blood sugar level were measured 
once a week. The baseline (day 0, before the treatment start) and final (day 15,after two 
weeks treatment) weight and fasting blood sugar level were examined and  recorded. 
 
1.3.4 Phytochemical screening 
 
Phytochemistry, or  easily defined as the chemistry of plants, is one of the early 
subdivisions of organic chemistry. This division is  importance in the identification of 
plant substances of medicinal value. It deals with the the study of chemicals derived 
from plants (phytochemicals). Phytochemicals are chemical compounds such as β-
carotene that occur naturally in plants. The term is generally used to refer to those 
chemicals that may affect health, but are not yet established as essential nutrients 
(Satyanand Tyagi., 2010) 
However, the use of phytochemicals comes with a caution sign. These 
compounds were not always beneficial under all circumstances especially in high doses. 
Certain biochemicals and vitamins,  have been found to encourage the growth of cancer 
cells and their use is being discouraged in patients undergoing cancer treatments. 
Although it has many benefits in certain conditions, high doses of beta-carotene 
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supplements are associated with an increased risk of lung cancer in male smokers. 
(Russel R et al., 1999) 
With the development of new phytochemical methods, new information has 
become available for use in conjunction with plant taxonomy; which contributed to the  
modern field of chemotaxonomy, or biochemical  (Britannica.com., accessed on 23 Jan 
2011). 
 
 
 
*SAR studies (Structure-activity-relationship studies) 
 
Figure 1.1  Flow chart for the study of plants used in traditional  medicine (Luc Pieters 
and  Arnold., 2005)  
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1.4  Swietenia macrophylla (SM) King  
 
 
Swietenia macrophylla King, from family Meliaceae is also known as big-leaf 
mahogany or Honduras mahogany. It is a tropical timber tree that can grow to a height 
of 40-60 m. This tree produces a fruit commonly called “sky fruit” because the fruit 
seems to hang upwards from the tree. In Malaysia,  the locals usually called it as 
‘Tunjuk Langit’. This plant is naturally distributed  from  the Atlantic regions of south-
east Mexico, through Central America, northern South America  and across the southern 
Amazon Basin, in Bolivia and Brazil,  but nowadays this plant  is cultivated in South 
East Asia region for various purposes (Lugo et al,2003). ‘Tunjuk Langit’ has been 
processed commercially to a wide range of health foods and healthcare products.  
 
 
 Scientific classification :  
 
 Kingdom:  Plantae 
                         Order:       Sapindales 
                         Family:     Meliaceae 
                        Genus:       Swietenia  
 Species :    S. macrophylla 
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Figure 1.2 : 
                
                        a)  Tree                                                                  b)  Leaves 
 
 
         
                          c)  Fruit                                                             d)  Seeds 
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This plant is an umbrella-shaped crown. fast-growing perennial tree with tall 
straight, cylindrical bole clear of branches for 12-18m, often with high buttresses. It has 
pinnate leaves arranged alternately and clustered at the ends of branchlets. Each leaf 
consists of  3- 6 pairs of opposite or occasionally subopposite leaflets that are typically 
9-14 x 3-5 cm, usually oblong to oblong-lanceolate or ovate-lanceolate (Lugo et 
al.,2003). 
 
1.4.1  The morphology of  fruit and  seeds of  S. macrophylla 
 
 
 
Figure 1.3  The fruit  of  S. macrophylla 
 
 
The fruits are large (12-15 x 6-8 cm), woody, erect, capsules, oblong to slightly 
sub-globulus. The outer valves are thick and becoming woody with a coriaceous surface 
when mature. When dry, the 4 or 5 valved fruits split open from the base, or from the 
base and the apex simultaneously. The centre of the fruit is a thick, woody 5 angled 
columella extending to the apex from which the seeds hang pendulous by their wing, 
leaving conspicuous seed scars after their release. 
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Figure 1.4  : The seeds of   S. macrophylla 
 
 
The seeds are chestnut colored and  7.5-12 cm in length with wings. There are 
arranged in  irregular forms inside the fruit. There are usually about 35-45 winged seeds 
per fruit  and it  takes  around 13,000 to 20,000 seeds to reach a kilogram weight. This 
seeds  ripen from the  end of January to beginning of  March  and  varies according to 
location. 
 
1.4.2  Phytochemistry of   Swietenia  macrophylla   
 
 Phytochemical  study of  Swietenia macrophylla King has revealed various 
compound  exist in this plant. The first phytochemistry study on  S. macrophylla  was 
reported in 1951 by Guha Sircar et al where they successfully  isolate two  
tetranotriterpenoids  known  as swietenine (figure 1.5) and swietenolide. Later, Mootoo  
et al  in 1999,  reported that, upto fifteen limonoids have been isolated from S. 
macrophylla, which are 7-deacetoxy-7-oxogedunin, andirobin (figure 1.8), and  thirteen 
bicyclononanolides. In 1999, they successfully discovered another two new compounds 
which are  augustineolide and 3β,6-dihydroxydihydrocarapin from the same plant . In 
addition, they also mentioned another nine known compounds that have been identified 
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from S. macrophylla  which are; proceranolide, 6-O acetylswietenolide, 3,6-O,O- 
diacetylswietenolide, Khayasin T, Swietemahonins E-G, 2-hydroxyswietenine and 6-
deoxyswietenine also known as febrifugin (figure 1.10). 
Further  phytochemical investigations have revealed the presence of limonoids 
such as  8, 30-epoxyswietenine acetate, swietenine acetate, swietenolide diacetate (figure 
1.6), and swietenolide tiglate, in the seeds of S. macrophylla (Chakravarty & Chatterjee, 
1955; Chakravarty, Chatterjee, & Krishnagar, 1957; Chan, Tang, & Toh, 1976; 
Connolly, Henderson, McCrindle, Overton, & Bhacca, 1964; Connolly & Labbe, 1980; 
Ghosh, Chakrabartty, & Chatterjee, 1960).  
Other parts of the plant, which is the leaves of  S. macrophylla, have been 
reported to yield essential oils which contain himachalene, germacrene D, germacrene 
A, cadina-1,4-diene, hexadecanoic acid, and ethyl hexadecanoate (Marisi et al., 2003). 
Seok-Keik Tan et al in 2009, also mentioned four new phragmalin-type limonoids, 
named swietephragmin H-J and  swietemacrophine have been isolated from the leaves of 
S. macrophylla King. The barks of S. macrophylla have been reported to possess 
triterpenoids, limonoids, flavonoids and tannins according to Guha Sircar et al in 1951 
and Mootoo et al in 1999. 
 
Figure 1.5   
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Figure 1.6  Swietenolide diacetate                       Figure 1.7  Swietenolide monohydrate 
 
 
 
                                                    Figure 1.8  Andirobin 
                       
  
         Figure 1.9  Swietemahonin A                                    Figure 1.10  Febrifugin                            
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  1.4.3 Medicinal  value of  S. macrophylla 
 
Herbal medicines have been used since the dawn of civilization to maintain 
health and to treat disease. There is a tremendous historical legacy in folklore uses of 
plant preparations in medicines. Scientific studies on plants used in ethnomedicine led to 
the discovery of many valuable drugs (Shylesh BS and Padikkale J, 2000).  
The seeds of S. macrophylla have been used for Leishmaniasis and abortion 
medicine by an Amazonian Bolivian ethnic group (Bourdy et al.,2000) and  for  
treatment of  hypertension, diabetes and malaria as folk medicines  in Indonesia (Kadota 
et al., 1990a). Murningsih et al  in 2005, reported anti-malarial activity of   water extract 
of  S. macrophylla seeds against Plasmodium  falciparum  . The seeds also have 
antibabesial (Murningsih et al.,2005) and anti-diarrhoeal activities (Maiti et al.,2007). 
The seeds also have been reported to possess antiinflammatory, antimutagenicity and 
antitumor activity (Maiti et al., 2007).  
In Malaysia, the seeds of  S. macrophylla, are used as a folk medicine for treating 
diabetes and high blood pressure (Chan et al, 1976).  A  decoction of the crushed seeds 
of this tree is also used to treat skin ailments and wounds (Munoz et al, 2000). The seeds 
are also used for  diarrhea  and a survey of literature showed that the organic and 
aqueous extracts of S. macrophylla seeds possess a wide array of biological properties 
including anti-diabetic (Maiti et al, 2007a) . In the same year, Maiti et al also discovered 
that  S. macrophylla  also possess anti-diarrhoeal (Maiti et al,2007b)  and  antibabesial 
activities (Maiti et al,2007c). Anti-microbial and anti-malarial activities have also  been 
reported with this plant (Soediro et al,1990, Jean et al, 2000). 
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Guevera AP et al in 1996, mention that the seed of  S.macrophylla  had been 
reported to have anti-inflammatory, antimutagenicity, and anti-tumor activities. 
S.macrophylla also have been shown to exhibit insect antifeedant activities (Nsiama et 
al., 2008), anti-fungal  (Govindachari et al., 1999) and in Malaysia, the seeds are used as 
a folk medicine for treatment of  hypertension (Chan, Tang, & Toh, 1976). Munoz  et al 
(2000) reported  that this plant also has anti-inflammatory activity. The barks of  S. 
macrophylla  also reported to possess anti-HIV, antimicrobial, antimalarial, and 
antitumor activities (Munoz et al, 2000) . 
 
 
1.5 Diabetes mellitus, (DM) disease of the millennium  
 
 Diabetes  is one of  the oldest diseases known to mankind. It was first mentioned  
in the Ebers Payrus  (Egypt 1500BC) and  also called as ‘honey urine’  by Sushrutha in 
India in 400 BC (Larry A. Distiller.,1980). The Latin word  ‘mel’ which  means honey 
was used, and the disease came to be known as diabetes  mellitus  that is, the passing of  
honeyed urine. This is still the full name of the disease. 
 Diabetes occur when the quantity of insulin produced  is  too little to allow for 
glucose to be used  or to be stored. In other words, this disease will appear when a 
person’s body does  not  make enough  insulin or cannot use insulin properly. Therefore, 
the hallmark of diabetes, which is due to insulin deficiency, is a rapid increase in the 
level  of glucose in the blood to more than normal  levels.  
 Diabetes can be divided  into two groups : Type 1 which is known as insulin 
dependant  diabetes  mellitus  (idDM) and also Type 2 ; non-insulin dependant diabetes 
mellitus (nidDM). 
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According  to World Health Organization (WHO) data, based on  a survey 
conducted in 1996 in Malaysia , it was estimated that around  700,000 to  900,000 adults 
aged 30 and  above  were having diabetes or  there are 8 diabetic patients in every 100 
adults.   
 
1.5.1 What causes diabetes?  
The causes of  diabetes  mellitus  are rather  ill understood even  now. However, 
as mentioned previously, the most important cause of  diabetes mellitus is the failure of 
beta cells in the pancreas  to secrete the insulin hormone sufficiently to the body needs. 
Causes of  type 1 diabetes differs from type 2 in many aspects . Type 1 diabetes  is 
mainly  due to the destruction of  insulin-producing beta cells of the pancreas  with 
resulting loss of insulin production. The actual process causing  the damage of the beta 
cells is still unknown although there are many theories.  
As for type 2 diabetes,  which usually develops gradually, differs greatly  from 
the type 1. The cause is unknown.  One type of  type 2 is associated  with obesity with 
marked insulin resistance. Many factors are blamed  for  the cause of  this type of 
diabetes but  recently  more interest has been  shown in the possibility of  faulty neural 
mechanisms of metabolic control.  Unlike type 1 diabetes, islet cell antibodies are not 
found in type 2 diabetes.  Table 3 shows some of  the causes of  diabetes mellitus. 
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Table 1.3 : Causes of  diabetes mellitus  (Lee Y.S., 1991). 
 
 
 
 
 
 
CAUSES OF DIABETES MELLITUS 
 
 
TYPE 1 : 
a) Viral Infection                                ?mumps 
                                                        ?Coxsackie B4 virus 
                                                                    ? Rubella 
b) Hereditary 
c) Auto- immunity 
d) Toxin to Islet cells. 
 
 
TYPE 2 : 
a) Hereditary +                               i  ? diet 
                                                   ii  ? exercise 
b) Obesity 
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1.5.2 Pathophysiology  of diabetes mellitus (DM) 
Glucose is a simple sugar found in food. Glucose is an essential nutrient that 
provides energy for the proper functioning of the body cells. Carbohydrates are broken 
down to glucose in the small intestine, and the glucose  is then absorbed by the intestinal 
cells into the bloodstream, and is carried by the bloodstream to all the cells in the body 
where it is utilized. However, glucose cannot enter the cells alone and needs insulin to 
aid in its transport into the cells. Without insulin, the cells become starved of glucose 
energy despite the presence of abundant glucose in the blood stream. The abundant, 
unutilized glucose is wastefully excreted in the urine.  
Insulin is a hormone that is produced by specialized cells (beta cells) of the 
pancreas. (The pancreas is a deep-seated organ in the abdomen located behind the 
stomach). In addition to helping glucose enter the cells, insulin is also important in 
tightly regulating the level of glucose in the blood. After a meal, the blood glucose level 
rises. In response to the increased glucose level, the pancreas normally releases more 
insulin into the bloodstream to help glucose enter the cells and lower blood glucose 
levels after a meal. When the blood glucose levels are lowered, the insulin release from 
the pancreas is turned down. As outlined above, in patients with diabetes, the insulin is 
either absent, relatively insufficient for the body's needs, or not used properly by the 
body. All of these factors cause elevated levels of blood glucose (hyperglycemia). Over 
a period of time, high glucose level in the bloodstream can lead to severe complications, 
such as eye disorders, cardiovascular diseases, kidney damage and nerve problems. 
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Figure 1.11: Overview of the pathogenesis of type 2 diabetes mellitus                                        
( adopted from (http://www.pharmainfo.net ) 
 
1.5.3  Treatment for diabetes mellitus (DM) 
When diet and exercise  unable to lower the raised blood sugar level to an 
acceptable value,  the  use of drugs became  a must. Many Type 2 diabetics will require 
the use of  hypoglycaemic drugs to lower the blood sugar. However, almost all Type 1 
diabetics will not respond to oral hypoglycaemic drugs, hence the only way to overcome 
this type of diabetes is through administration of Insulin.  Generally, there are  four  
main groups of oral  hypoglycaemic agents (OHA)  available for the treatment of  
diabetes, which are classified according to their mode of  actions. They are Insulin 
secretagogues, insulin sensitizers, α-glucosidase inhibitors and biguanide (Lebovitz  
2001). 
 
* FFA = free fatty acid 
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1.5.3.a   Insulin Secretagogues. 
Insulin secretagogues can be divided into 2 subclasses: sulfonylureas and non-
sulfonylureas. The basic action of sulphonylureas is normalizing the release of insulin by 
some healthy  β-cells of the pancreas (Lee Y.S.,1991). It also reduces the production of 
glucose in the liver and the absorption of glucose from  the gut. Some sulphonylureas 
are said to enhance insulin sensitivity in the peripheral tissues. Sulfonylureas that are 
currently available are glipizide, gliclazide, glibenclamide, glimerpide and  glyburide. 
As for the non-sulphonylureas, the mechanism of action of these drugs is similar to that 
of the sulfonylureas , except  they bind to the sulfonylurea receptor at a different site and 
with different kinetics than the sulfonylureas. Nateglinide and repaglinide are some of 
the drugs belong to this group. 
 
1.5.3.b  Insulin Sensitizers  
Thiazolidinediones (TZD) are the main insulin sensitizers  currently available. 
Examples of  TZDs are rosiglitazone and  pioglitazone. TZDs  are selective agonists for 
the peroxisome proliferator-activated receptor gamma (PPAR γ), which is most highly 
expressed in adipocytes. These nuclear receptors, which are ligand-activated 
transcription factors, play an integral part in the regulation of the expression of a variety 
of genes involved in carbohydrate and lipid metabolism (Lebovitz.,2001). TZDs  require 
insulin to be present for their activity, where they increase the insulin sensitivity, 
particularly in the peripheral tissues. 
 
 
 
